Anorexins, asthenins, and cachectins in cancer
- 31 October 1986
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 81 (4), 696-698
- https://doi.org/10.1016/0002-9343(86)90558-9
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- CACHECTIN/TUMOUR-NECROSIS-FACTOR PRODUCTION BY CANCER PATIENTSThe Lancet, 1985
- Tumor Necrosis Factor (TNF)Science, 1985
- A Macrophage Factor Inhibits Adipocyte Gene Expression: An in Vitro Model of CachexiaScience, 1985
- ANTI-TUMOUR THERAPY BY INDUCTION OF ENDOGENOUS TUMOUR NECROSIS FACTORThe Lancet, 1985
- Identity of tumour necrosis factor and the macrophage-secreted factor cachectinNature, 1985
- Effect of tumour necrosis factor on growth of Ehrlich ascites tumour cells in vitro and in vivoCancer Letters, 1985
- Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells.The Journal of Experimental Medicine, 1985
- Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude miceInternational Journal of Cancer, 1984
- Asthenia in cancerThe American Journal of Medicine, 1982
- Studies of endotoxin-induced decrease in lipoprotein lipase activity.The Journal of Experimental Medicine, 1981